After subgrouping our cohort, we found that AGR3 has a significant (P < 0.05) prognostic impact in the low (G1) and intermediate (G2) grade tumours (Fig. 3B and Table 1), but not in the group of high grade (G3) cases (Fig. 3C). This evidence concerns the gene AGR3 and neoplasm.